Skip to main content

Result releasedAnnolyse analysis published

Chatswood Retirement Limited acquisition puts Promisia Healthcare's debt headroom in focus

The NZ$25m acquisition price is relevant to debt headroom, while borrowings and gearing remain the direct evidence.

PHL revenue trajectory

Revenue context before the current result.

Loading chart...
FY26 was $40.1m, versus $29.9m in FY24.

PHL EBITDAF margin

EBITDAF margin across covered periods.

Loading chart...
FY26 was 16.5%, versus 15% in FY23.

PHL operating cash flow

Operating cash flow across covered periods.

Loading chart...
FY26 was $6.4m, versus $7.5m in FY24.

PHL NPAT trajectory

Statutory profit after tax across covered periods.

Loading chart...
FY26 was $12.9m, versus $1.6m in FY24.

Market context

Valuation

These ratios pair a market close from around the result date with verified filing data. An unavailable metric means the required inputs were missing or unsuitable for comparison.

Prices as at close, 20 November 2026

Price and market cap

The latest close and share count context for the market price.

Market cap

$33.6m

i

End-of-day close multiplied by current shares on issue.

Profitability multiples

How the market price compares with recent earnings and cash-flow inputs.

P/E

Not available

i

Not available for this company right now.

EPS

Not available

i

Not available for this company right now.

PEG

Not available

i

Not available for this company right now.

EV/EBITDA

Not available

i

Not available for this company right now.

P/FCF

Not available

i

Not available for this company right now.

P/B

0.59x

i

Market value compared with latest reported equity.

Income and investment-company measures

Yield and investment-company valuation where supported.

Dividend yield

0.0%

i

Trailing dividends compared with the latest close.

Total return

Not available

i

Available once dividend and adjustment data are verified.

Release date
11 November 2026
Published
11 November 2026

Key metrics

Numbers worth scanning first

HY27 vs HY26

Revenue

$21.8m

Caveat: metric quality flags apply; use this value with basis context.

Net profit after tax

$1.3m

Caveat: metric quality flags apply; use this value with basis context.

Net cash inflow from operating activities

$2.3m

Caveat: metric quality flags apply; use this value with basis context.

Interim dividend per share

0.72c

— vs —

Profit before tax

$2m

Caveat: metric quality flags apply; use this value with basis context.

Cash and cash equivalents

$0.11m

-12.6% ↓ vs $0.13m

Total assets

$202.8m

Caveat: metric quality flags apply; use this value with basis context.

Analysis ofPHL HY27Result releasedAnnolyse analysis published

What changed

Promisia Healthcare’s operating cash flow fell to NZD 2.3 million from NZD 2.8 million despite stronger HY27 earnings, making cash generation the main qualification to the profit recovery

Current cash conversion was 61.0% of underlying EBITDAF; a comparable prior-period ratio is unavailable, so a conversion trend cannot be established.

Revenue increased 13.7% to NZD 21.8 million. Underlying EBITDAF was NZD 3.8 million, with management citing NZD 2.55 million for HY26. Statutory profit before tax rose to NZD 2.0 million from NZD 0.2 million, while NPAT moved from a NZD 49,000 loss to a NZD 1.3 million profit.

Gross borrowings declined to NZD 41.7 million from NZD 43.5 million, but cash remained just NZD 0.1 million. No segment breakdown is available to establish which facilities or revenue streams contributed most to the improvement.

What matters

Cash performance qualifies the earnings recovery

Chatswood Retirement Limited acquisition adds balance-sheet context, with NZ$25m acquisition price, but borrowings and gearing are the direct leverage evidence.

  • Lower operating cash flow means the stronger income statement did not produce a matching increase in cash available to support investment and financing commitments. The supplied disclosures do not identify the cause, so neither collection timing nor working-capital pressure can be asserted.

  • Operating improvement is more informative than the statutory profit rebound alone. Underlying EBITDAF excludes fair-value adjustments and items considered non-trading in nature or size, making it the issuer’s preferred operating measure. For an aged-care business, sustained occupancy, care funding and staffing costs are essential to judging durability, but the supplied material does not quantify their individual contributions.

  • Debt reduction improves the balance-sheet position, but liquidity remains important. Calculated net debt, defined as gross borrowings less cash, was NZD 41.6 million versus NZD 43.3 million. The small cash balance means financial flexibility depends on ongoing cash generation and available funding facilities, whose headroom is not supplied.

Expectations

The stated FY27 underlying EBITDAF target is at least NZD 9.0 million, compared with NZD 3.8 million earned in the first half

That establishes a numeric commitment, but the supplied material does not provide a sufficiently clear operating bridge to judge delivery confidence. Investors need to distinguish the earnings already demonstrated from the assumptions supporting the full-year target.

FY26 revenue was modestly second-half weighted: HY26 contributed 47.8% of annual revenue. That offers limited context rather than a dependable earnings-seasonality rule. Management cites sustained high occupancy, while the prior release referred to a 95% site occupancy target; current facility-level occupancy and performance against that threshold are not supplied, limiting assessment of remaining operating upside.

Quality of result

Chatswood acquisition adds cash-flow context, with NZ$20m acquisition price, but the filing does not separately reconcile the transaction to the financial movement

The result contains evidence of better operating earnings, but weaker statutory operating cash flow prevents an unqualified quality assessment. Capital expenditure increased to NZD 0.8 million from NZD 0.3 million, contributing to calculated pre-lease free cash flow falling to NZD 1.5 million from NZD 2.5 million. Capex affects this free-cash-flow measure, not operating cash conversion. Separate current trade receivables and a quantified working-capital cash-flow movement are unavailable, leaving the cash-flow explanation unresolved.

Company-defined Operating Free Cash Flow was NZD 1.0 million. Its definition starts with underlying EBITDAF and deducts cash interest, committed debt repayments, cash tax payable and maintenance capex; it is not directly comparable with calculated pre-lease free cash flow. The company’s disclosed dividend payout was 38.2% of its free-cash-flow measure. This supports assessment of the current interim distribution, not an annual dividend policy or proof that statutory cash generation strengthened.

Unresolved

Open questions

What explains lower operating cash flow despite higher revenue and underlying EBITDAF?
How much of the operating earnings improvement came from occupancy, care pricing, staffing efficiency and other cost changes?
What facility-level occupancy and staffing assumptions support the FY27 earnings target?
How much undrawn funding headroom is available, and what minimum liquidity does management intend to maintain?

This briefing cannot assess facility-level profitability, funding headroom or the durability of cash generation from the supplied disclosures.

Ask about PHL HY27

Informational only. No buy, sell, hold, price-target, or personal financial advice.

Sign in to chat

Sign in to ask questions about Promisia Healthcare's HY27 result.

What explains lower operating cash flow despite higher revenue and underlying EBITDAF?Why does "Cash performance qualifies the earnings recovery" matter?How strong was the cash and earnings quality in HY27?What should I watch next for PHL after HY27?

Checking account...

Data appendix

Show analytical metrics

Open to load analytical metrics.

Show key metrics table

Open to load key metrics.

Sources

Current period

PHL HY27 Interim Report

HY27 / financial report

PHL HY27 NZX Results Announcement

HY27 / results announcement

PHL HY27 Results Announcement

HY27 / results release

Prior comparable period

PHL HY26 Preliminary Financial Statements

HY26 / financial report

PHL HY26 Results Announcement

HY26 / results release

PHL HY26 NZX Results Announcement

HY26 / results announcement

Full-year context

PHL 2026 Annual Report

FY26 / financial report

Release context

FY26 Earnings Guidance Upgrade

FY26 / commentary

Presentation - ASM 2025

HY26 / commentary

Presentation - ASM 2026

HY27 / commentary

Get notified when PHL publishes next

Get the next Promisia Healthcare briefing and related NZX reporting-season updates by email.